Beclometasone oral modified release
- Drugs List
- Therapeutic Indications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
Oral formulations of beclometasone.
Mild-to-moderate active ulcerative colitis: adjunctive treatment
5mg once a day taken in the morning before or after a light breakfast.
Children under 18 years
Severe hepatic impairment
Precautions and Warnings
Glucose-galactose malabsorption syndrome
History of steroid-induced psychosis
Consider supplementary corticosteroids if subject to stress or surgery
Exclude fungal infection before treatment
Exclude tubercular infection before treatment
Exclude viral infection before treatment
Initiate antibiotic therapy if intestinal infection occurs
If visual disturbances occur, perform ophthalmic evaluation
Prolonged or high dose may lead to adrenal suppression
Patient should report worrying psychological changes esp. suicidal thoughts
Not recommended for use longer than 4 weeks
Pregnancy and Lactation
Use beclometasone with caution during pregnancy.
The manufacturer does not recommend using beclometasone during pregnancy unless considered necessary after a risk benefit evaluation.
Data suggests there is no adverse health effects to the newborn when inhaling beclometasone in quantities of 1mg. There is limited data regarding doses greater than 1mg, including oral 5mg beclometasone dipropionate. High doses of systemic corticosteroids may cause intrauterine growth retardation when used for long periods. Animal studies have shown reproductive toxicity.
Use beclometasone with caution during breastfeeding.
The manufacturer does not recommend using beclometasone during breastfeeding, unless considered necessary after a risk benefit evaluation.
The presence of beclometasone in human breast milk is unknown. A risk to the newborn cannot be excluded.
Benign intracranial hypertension
Reduction in serum cortisol levels
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Last Full Review Date: August 2019
Summary of Product Characteristics: Clipper 5mg gastro-resistant prolonged release tablets. Chiesi Ltd. Revised May 2019.
NICE Evidence Services Available at: www.nice.org.uk Last accessed: 14 August 2019
US National Library of Medicine. Toxicology Data Network. Drugs and Lactation Database (LactMed).
Available at: https://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
Beclomethasone Last revised: 31 October 2018
Last accessed: 14 August 2019
Already a member? Log in
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.